167 related articles for article (PubMed ID: 35879438)
41. Primary cutaneous anaplastic large cell lymphoma with DUSP22-IRF4 rearrangement demonstrating a biphasic histopathologic pattern and a complete natural regression.
Kitajima Y; Yamashina M; Hanamoto M; Shijimaya T; Terai S; Nakamaru S; Makimura K; Inoue N; Takeuchi K; Kiyohara T
J Dermatol; 2022 Sep; 49(9):e309-e310. PubMed ID: 35560037
[No Abstract] [Full Text] [Related]
42. Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing.
Feldman AL; Dogan A; Smith DI; Law ME; Ansell SM; Johnson SH; Porcher JC; Ozsan N; Wieben ED; Eckloff BW; Vasmatzis G
Blood; 2011 Jan; 117(3):915-9. PubMed ID: 21030553
[TBL] [Abstract][Full Text] [Related]
43. Genetics of anaplastic large cell lymphoma.
Zeng Y; Feldman AL
Leuk Lymphoma; 2016; 57(1):21-7. PubMed ID: 26104084
[TBL] [Abstract][Full Text] [Related]
44. Genetic Subtypes of Systemic Anaplastic Large Cell Lymphoma Show Distinct Differences in PD-L1 Expression and Regulatory and Cytotoxic T Cells in the Tumor Microenvironment.
Ferreira CR; Manohar V; Zhao S; Bangs CD; Cherry A; Azevedo RS; Lage LAPC; Pereira J; Zerbini MCN; Gratzinger D; Natkunam Y
Appl Immunohistochem Mol Morphol; 2020 Jan; 28(1):10-16. PubMed ID: 31809310
[TBL] [Abstract][Full Text] [Related]
45. The clinicopathological relevance of uniform CD56 expression in anaplastic large cell lymphoma: a retrospective analysis of 18 cases.
Yu BH; Zhang Y; Xue T; Shui RH; Lu HF; Zhou XY; Zhu XZ; Li XQ
Diagn Pathol; 2021 Jan; 16(1):1. PubMed ID: 33402163
[TBL] [Abstract][Full Text] [Related]
46. Updates in pathobiological aspects of anaplastic large cell lymphoma.
Wu R; Lim MS
Front Oncol; 2023; 13():1241532. PubMed ID: 37810974
[TBL] [Abstract][Full Text] [Related]
47. PAX-5 Positivity in Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma: A Case Report and Review of Literature.
Arun I; Roy P; Arora N; Bhave SJ; Nair R; Chandy M
Int J Surg Pathol; 2017 Jun; 25(4):333-338. PubMed ID: 28013563
[TBL] [Abstract][Full Text] [Related]
48. Cutaneous presentation of enteropathy-associated T-cell lymphoma masquerading as a DUSP22-rearranged CD30+ lymphoproliferation.
Bisig B; Cairoli A; Gaide O; Somja J; Bregnard C; Gaulard P; Xerri L; Lefort K; Missiaglia E; Gilliet M; Hohl D; Guenova E; de Leval L
Virchows Arch; 2022 Oct; 481(4):653-657. PubMed ID: 35366115
[TBL] [Abstract][Full Text] [Related]
49.
Onaindia A; de Villambrosía SG; Prieto-Torres L; Rodríguez-Pinilla SM; Montes-Moreno S; González-Vela C; Piris MA
Haematologica; 2019 Apr; 104(4):e158-e162. PubMed ID: 30361415
[No Abstract] [Full Text] [Related]
50. The biology and management of systemic anaplastic large cell lymphoma.
Hapgood G; Savage KJ
Blood; 2015 Jul; 126(1):17-25. PubMed ID: 25869285
[TBL] [Abstract][Full Text] [Related]
51. [Detection of chromosomal translocations involving ALK gene in anaplastic large cell lymphoma by fluorescence in-situ hybridization and its clinical significance].
Huang WT; Li XQ; Yao XH; Lu YM; Sheng WQ; Lu HF; Zhou XY
Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):371-5. PubMed ID: 22932403
[TBL] [Abstract][Full Text] [Related]
52. ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient.
Pulitzer M; Ogunrinade O; Lin O; Steinherz P
J Cutan Pathol; 2015 Mar; 42(3):182-187. PubMed ID: 25404214
[TBL] [Abstract][Full Text] [Related]
53. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
Stein H; Foss HD; Dürkop H; Marafioti T; Delsol G; Pulford K; Pileri S; Falini B
Blood; 2000 Dec; 96(12):3681-95. PubMed ID: 11090048
[TBL] [Abstract][Full Text] [Related]
54. Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patients.
Wang YF; Yang YL; Gao ZF; Zhou CJ; Gregg X; Shi YF; Wang J; Yang XF; Ke XY
J Hematol Oncol; 2012 Jul; 5():38. PubMed ID: 22769020
[TBL] [Abstract][Full Text] [Related]
55. Histopathological features and outcomes of DUSP22 rearrangement in primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.
Nieto-Benito LM; Parra-Blanco V; Gómez-Navarro Y; Menárguez-Palanca J; Pulido-Pérez A
J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e670-e672. PubMed ID: 34014587
[No Abstract] [Full Text] [Related]
56. Advances in the treatment and prognosis of anaplastic lymphoma kinase negative anaplastic large cell lymphoma.
Wang X; Wu J; Zhang M
Hematology; 2019 Dec; 24(1):440-445. PubMed ID: 31072226
[TBL] [Abstract][Full Text] [Related]
57. Complete response in a critically ill patient with ALK-negative anaplastic large cell lymphoma treated with single agent brentuximab-vedotin.
Oregel KZ; Everett E; Zhang X; Nagaraj G
Expert Rev Anticancer Ther; 2016; 16(3):279-83. PubMed ID: 26809026
[TBL] [Abstract][Full Text] [Related]
58. Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes.
Mélard P; Idrissi Y; Andrique L; Poglio S; Prochazkova-Carlotti M; Berhouet S; Boucher C; Laharanne E; Chevret E; Pham-Ledard A; De Souza Góes AC; Guyonnet-Duperat V; Bibeyran A; Moreau-Gaudry F; Vergier B; Beylot-Barry M; Merlio JP; Cappellen D
Oncotarget; 2016 Oct; 7(42):68734-68748. PubMed ID: 27626696
[TBL] [Abstract][Full Text] [Related]
59.
Jiang Y; Wang L; Zhou W; Gu J; Tian Y; Dong Y; Fu L; Wu HB
Cancer Imaging; 2020 Jan; 20(1):4. PubMed ID: 31924270
[TBL] [Abstract][Full Text] [Related]
60. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Oishi N; Miranda RN; Feldman AL
Aesthet Surg J; 2019 Jan; 39(Suppl_1):S14-S20. PubMed ID: 30715169
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
